Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Warning:

This online archive of the CDC Prevention Guidelines Database is being maintained for historical purposes, and has had no new entries since October 1998. To find more recent guidelines, please visit the following:


Prevention Guidelines

Topic: Prevention Programs (AIDS)

(Please note that the documents listed below are sorted by date.)

Update: Syringe-Exchange Programs -- United States, 1996; 1997:06:20

Notice to Readers Publication of HIV-Prevention Bulletin for Health-Care Providers Regarding Advice to Persons Who Inject Illicit Drugs; 1997:06:06

Guidelines for Isolation Precautions in Hospitals Hospital Infection Control Advisory Committee; 1996:01:01

Update: Barrier Protection Against HIV Infection and Other Sexually Transmitted Diseases; 1993:08:06

Recommendations for Preventing Transmission of Human Immunodeficiency Virus and Hepatitis B Virus to Patients During Exposure-Prone Invasive Procedures; 1991:07:12

Current Trends Partner Notification for Preventing Human Immunodeficiency Virus (HIV) Infection -- Colorado, Idaho, South Carolina, Virginia; 1988:07:01

Perspectives in Disease Prevention and Health Promotion Update: Universal Precautions for Prevention of Transmission of Human Immunodeficiency Virus, Hepatitis B Virus, and Other Bloodborne Pathogens ; 1988:06:24

Perspectives in Disease Prevention and Health Promotion Semen Banking, Organ and Tissue Transplantation, and HIV Antibody Testing; 1988:02:05

Guidelines for Effective School Health Education To Prevent the Spread of AIDS; 1988:01:29

Guidelines for AIDS Prevention Program Operations; 1987:10:01

Recommendations for Prevention of HIV Transmission in Health-Care Settings; 1987:08:21

Perspectives in Disease Prevention and Health Promotion Public Health Service Guidelines for Counseling and Antibody Testing to Prevent HIV Infection and AIDS; 1987:08:14

Current Trends Recommendations for Preventing Transmission of Infection with Human T-Lymphotropic Virus Type III/ Lymphadenopathy-Associated Virus during Invasive Procedures; 1986:04:11

Current Trends Additional Recommendations to Reduce Sexual and Drug Abuse-Related Transmission of Human T-Lymphotropic Virus Type III/ Lymphadenopathy-Associated Virus; 1986:03:14

Current Trends Recommendations for Assisting in the Prevention of Perinatal Transmission of Human T-Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus and Acquired Immunodeficiency Syndrome; 1985:12:06

Current Trends Summary: Recommendations for Preventing Transmission of Infection with Human T-Lymphotropic Virus Type III/ Lymphadenopathy-Associated Virus in the Workplace; 1985:11:15

Recommendations for Preventing Transmission of Infection with Human T-Lymphotropic Virus Type III/ Lymphadenopathy-Associated Virus in the Workplace; 1985:11:15

Current Trends Recommendations for Preventing Possible Transmission of Human T-Lymphotropic Virus Type III/ Lymphadenopathy- Associated Virus from Tears; 1985:08:30

Prospective Evaluation of Health-Care Workers Exposed via Parenteral or Mucous-Membrane Routes to Blood and Body Fluids of Patients with Acquired Immunodeficiency Syndrome; 1984:04:06

Acquired Immunodeficiency Syndrome (AIDS): Precautions for Health-Care Workers and Allied Professionals; 1983:09:02

Epidemiologic Notes and Reports An Evaluation of the Acquired Immunodeficiency Syndrome (AIDS) Reported in Health-Care Personnel -- United States; 1983:07:15

Current Trends Prevention of Acquired Immune Deficiency Syndrome (AIDS): Report of Inter-Agency Recommendations; 1983:03:04

Current Trends Acquired Immune Deficiency Syndrome (AIDS): Precautions for Clinical and Laboratory Staffs; 1982:11:05




This page last reviewed: Wednesday, January 27, 2016
TOP